Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cyclophosphamide (cytoxan) (2 trials)
egf-rp64k (1 trial)
egf vaccine (1 trial)
montanide isa51 (1 trial)
recombinant human regf-p64k/montanide vaccine (1 trial)
egf-pti (1 trial)
gefitinib (iressa) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Lung Neoplasms (Phase 3)
Trials (4 total)
Trial APIs (7 total)